Lataa...
Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis
BACKGROUND: Both the US FDA and the European Medicines Agency (EMA) have approved aripiprazole for use in adolescents for specific indications. Given the assumed favorable side-effect profile of aripiprazole, its use in children and adolescents has increased for both official and off-label indicatio...
Tallennettuna:
| Julkaisussa: | CNS Drugs |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4996892/ https://ncbi.nlm.nih.gov/pubmed/27395403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-016-0367-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|